Newsroom

Sorted by: Latest

-

Vigil: The First Open-Source AI SOC Built with a LLM-native Architecture

SAN FRANCISCO--(BUSINESS WIRE)--Security teams are trapped between proprietary AI SOC vendors that obscure model intelligence and open-source tools that haven’t kept up with agentic architectures. A new open-source project, Vigil, launched at RSA today, changes that. Vigil, built by DeepTempo, enhances rather than obfuscates the transformative intelligence of rapidly advancing reasoning models, including Anthropic’s Claude. Available immediately under an Apache 2.0 license, Vigil ships with 13...
-

iOPEX Unveils 'FieldPilot', Bringing Agentic AI to Field Engineering Services

SAN JOSE, Calif.--(BUSINESS WIRE)--iOPEX Technologies unveils FieldPilot, bringing agentic AI to field engineering services....
-

RFMW and JARO Thermal Announce Distribution Agreement for Advanced Thermal Management Solutions

SAN JOSE, Calif.--(BUSINESS WIRE)--RFMW, a Division of Exponential Technology Group, Inc., a premier distributor of RF, microwave, and power management and conversion components, today announced a new distribution agreement with JARO Thermal, a global leader in advanced electronic cooling technologies. This strategic partnership expands RFMW’s portfolio with JARO’s comprehensive range of thermal management solutions designed to extend the life and performance of electronic components and high-p...
-

Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mu...
-

Biocom Appoints New Members to Its Board of Directors

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, today announced the appointment of Aaron K. Cohen, vice president, government affairs and public policy at Neurocrine Biosciences and Bradley Wolff, senior managing director at Evercore, to its board of directors. “Mr. Cohen and Mr. Wolff are valuable additions to our board of directors, which co...
-

Graylog Earns Two Global InfoSec Awards at RSA Conference 2026 for SIEM and Central Log Management Innovation

SAN FRANCISCO--(BUSINESS WIRE)--Accolades include being named Hot Company Security Information and Event Management (SIEM) and winning Best Solution Central Log Management....
-

MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition

CAYMAN ISLANDS--(BUSINESS WIRE)--MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant long-term shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”), today issued the following statement in response to the Company’s announcement that Kevin Tang has been appointed Chief Executive Officer, effective immediately. Antoine Khalife, Founder of MKT Capital, stated: “Today marks a watershed moment for Aurinia shareholders. Since 2019,...
-

CyberProof Unveils Reveal360 Hub for Security and Business Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--CyberProof, a UST company, leading provider of co-managed security services, announced the availability of CyberProof Defense Center (CDC) Reveal360....
-

P0 Reports Compounding Customer and Market Momentum as Enterprises Modernize Privileged Access Across the Full Production Stack

SAN FRANCISCO--(BUSINESS WIRE)--P0 Security announces strong growth & adoption as enterprises modernize privileged access, eliminating standing privilege across hybrid environments....
-

Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small-Molecule API Manufacturing Capacity in Delaware

NEWARK, Del.--(BUSINESS WIRE)--Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 million expansion of its Delaware campus to more than double its current API reactor capacity, supporting growing demand for high-quality, U.S.-based manufacturing. The expansion will add two new 10,000-liter reactor suites, significantly increasing Wilmington’s comme...